1887
Articles Open Access
Like 0
This item has no PDF Download
  • Improving surveillance of varicella in Europe in response to increasing availability of varicella vaccine separator commenting unavailable

  • J Edmunds
  • View Citation Hide Citation

    Citation style for this article: Edmunds J. Improving surveillance of varicella in Europe in response to increasing availability of varicella vaccine. Euro Surveill. 2002;6(32):pii=1903. https://doi.org/10.2807/esw.06.32.01903-en

Abstract

Last week, the United Kingdom received its first licensed varicella (chickenpox) vaccine. Despite the availability of the new vaccine there are currently no plans to introduce it into the routine immunisation schedule in the UK (currently the vaccine is licensed only for susceptible individuals over the age of 12 years and younger individuals who may be in contact with high risk patients). Indeed, European countries have been slow to introduce widespread chickenpox vaccination, despite the apparent success of the programme in reducing chickenpox incidence in the United States (1). This may be due to a lack of perceived need for chickenpox vaccine among parents and healthcare professionals as observed in Canada, along with concerns regarding the safety of the vaccine when used in routine programmes (2). There are two safety concerns: first, that an inadequate chickenpox vaccination programme will lead to an increase in adult cases (which are generally more severe); and second, that vaccination will lead to an increase in zoster (shingles) in the medium term. What is the basis for these concerns and what surveillance data are available from countries that have introduced the vaccine (notably the US) that may shed light on these issues?

Loading

Article metrics loading...

/content/10.2807/esw.06.32.01903-en
2002-08-08
2024-03-29
http://instance.metastore.ingenta.com/content/10.2807/esw.06.32.01903-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/6/32/art01903-en.htm?itemId=/content/10.2807/esw.06.32.01903-en&mimeType=html&fmt=ahah
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error